These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9813621)

  • 61. Heparin sulfate in the stone matrix and its inhibitory effect on calcium oxalate crystallization.
    Yamaguchi S; Yoshioka T; Utsunomiya M; Koide T; Osafune M; Okuyama A; Sonoda T
    Urol Res; 1993 May; 21(3):187-92. PubMed ID: 8342253
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cancer-related urinary proteinase inhibitor, EDC1: a new method for its isolation and evidence for multiple forms.
    Chawla RK; Lawson DH; Ahmad M; Travis J
    J Cell Biochem; 1992 Nov; 50(3):227-36. PubMed ID: 1469060
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Plasma inter-alpha-trypsin inhibitor-related urinary glycoprotein EDC1 inhibits the growth of a Burkitt's lymphoma cell line.
    Chawla RK; Lawson DH; Travis J
    J Cell Biochem; 1990 Apr; 42(4):207-17. PubMed ID: 1692840
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Morphological typing of calcium oxalate calculi and etiopathogenic findings].
    Daudon M; Reveillaud RJ
    Ann Urol (Paris); 1985; 19(5):299-308. PubMed ID: 4083837
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Defective urinary crystallization inhibition and urinary stone formation.
    Carvalho M; Lulich JP; Osborne CA; Nakagawa Y
    Int Braz J Urol; 2006; 32(3):342-8; discussion 349. PubMed ID: 16813682
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Proteoglycan core protein in human urine and its possible role on calcium oxalate urolithiasis.
    Yoshimura K; Miyake O; Tsujihata M; Yoshioka T; Yamaguchi S; Koide T; Takahara S; Okuyama A
    Int J Urol; 1999 Nov; 6(11):567-71. PubMed ID: 10585122
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Zeta potential measurement and particle size analysis for a better understanding of urinary inhibitors of calcium oxalate crystallization.
    Cao LC; Deng G; Boevé ER; de Bruijn WC; de Water R; Verkoelen CF; Romijn JC; Schröder FH
    Scanning Microsc; 1996; 10(2):401-11; discussion 412-4. PubMed ID: 9813619
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Model of calcium oxalate lithogenesis by kinetic turbidimetry].
    Beaufays JP; Bouche R; Boistelle R
    Nephrologie; 1993; 14(6):271-81. PubMed ID: 8145885
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Renal stones. Solutions and solute.
    Smith LH
    Endocrinol Metab Clin North Am; 1990 Dec; 19(4):767-72. PubMed ID: 2081509
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Urinary bikunin determination provides insight into proteinase/proteinase inhibitor imbalance in patients with inflammatory diseases.
    Mizon C; Piva F; Queyrel V; Balduyck M; Hachulla E; Mizon J
    Clin Chem Lab Med; 2002 Jun; 40(6):579-86. PubMed ID: 12211652
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Assembly and secretion of recombinant chains of human inter-alpha-trypsin inhibitor in COS-7 cells.
    Martin-Vandelet N; Paris S; Bourguignon J; Sesboüé R; Martin JP; Diarra-Mehrpour M
    Eur J Biochem; 1999 Jan; 259(1-2):476-84. PubMed ID: 9914530
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Is there a role for pentosan polysulfate in the prevention of calcium oxalate stones?
    Jones M; Monga M
    J Endourol; 2003 Dec; 17(10):855-8. PubMed ID: 14744348
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Urinary kidney stone inhibitors. Where are we?
    Dussol B; Berland Y
    Nephrol Dial Transplant; 1996 Jul; 11(7):1222-4. PubMed ID: 8672008
    [No Abstract]   [Full Text] [Related]  

  • 74. Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily.
    Shiraga H; Min W; VanDusen WJ; Clayman MD; Miner D; Terrell CH; Sherbotie JR; Foreman JW; Przysiecki C; Neilson EG
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):426-30. PubMed ID: 1729712
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Retardation of calcium oxalate formation by polyacidic peptides.
    Garti N; Sarig S; Tibika F
    Invest Urol; 1980 Sep; 18(2):149-50. PubMed ID: 6157654
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Presence of the protein-glycosaminoglycan-protein covalent cross-link in the inter-alpha-inhibitor-related proteinase inhibitor heavy chain 2/bikunin.
    Enghild JJ; Salvesen G; Thøgersen IB; Valnickova Z; Pizzo SV; Hefta SA
    J Biol Chem; 1993 Apr; 268(12):8711-6. PubMed ID: 7682553
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Human protein HC (alpha 1-microglobulin) and inter-alpha-trypsin inhibitor in connective tissue.
    Odum L; Nielsen HW
    Histochem J; 1994 Oct; 26(10):799-803. PubMed ID: 7533752
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bikunin--not just a plasma proteinase inhibitor.
    Fries E; Blom AM
    Int J Biochem Cell Biol; 2000 Feb; 32(2):125-37. PubMed ID: 10687949
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Kunitz-type proteinase inhibitors derived by limited proteolysis of the inter-alpha-trypsin inhibitor, I. Determination of the amino acid sequence of the antitryptic domain by solid-phase Edman degradation.
    Hochstrasser K; Wachter E
    Hoppe Seylers Z Physiol Chem; 1979 Sep; 360(9):1285-96. PubMed ID: 92447
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Human leucocyte elastase (HLE) preferentially cleaves the heavy chain H2 of inter-alpha-trypsin inhibitor (ITI).
    Balduyck M; Piva F; Mizon C; Maes P; Malki N; Gressier B; Michalski C; Mizon J
    Biol Chem Hoppe Seyler; 1993 Sep; 374(9):895-901. PubMed ID: 7505589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.